3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Small Cell Lung Carcinoma
2
Neoplasms
2
Head and Neck Neoplasms
2
Gastrointestinal Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Merkel Cell
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Turcot syndrome
1
Stomach Neoplasms
1
Sarcoma
1
Penile Neoplasms
1
PD-L1 Positive Mutation Tumor
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Melanoma
1
Lymphoma, Extranodal NK-T-Cell
1
Leukemia, Myeloid, Chronic-Phase
1
Hodgkin Disease
1
Hemangiosarcoma
1
Glioblastoma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Interventions
Cyclophosphamide
6
fludarabine phosphate
5
Busulfan
5
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
Imatinib Mesylate
4
Hydroxyurea
4
Cytarabine
4
Antilymphocyte Serum
4
Radiotherapy
3
Melphalan
3
Interferon-alpha
3
Dasatinib
3
olverembatinib
2
Tacrolimus
2
Polymerase Chain Reaction
2
Methylprednisolone
2
Idarubicin
2
Filgrastim
2
Cyclosporine
2
Cord Blood Stem Cell Transplantation
2
sargramostim
1
nilotinib
1
inecalcitol
1
flumatinib
1
danusertib
1
avelumab
1
Whole-Body Irradiation
1
Tyrosine Kinase Inhibitors
1
Rituximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Leukemia, Myeloid, Chronic-Phase
×
avelumab
×
Clear all
NCT02767063
2020-08-07
ACTIW
Versailles Hospital
Phase 1/2
Unknown
100 enrolled